AOLS.US Aeolus Pharmaceuticl

Healthcare Pharmaceuticals USA Stocks
0.0001 USD
Close of Apr 1, 2026
0.0001 0.0001
Market cap
USD 15.2K
P/E
-
P/B
0.81x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2023.

Is AOLS.US undervalued?

Graham number

The Graham number of Aeolus Pharmaceuticl cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Aeolus Pharmaceuticl fundamental analysis

No fundamental analysis for Aeolus Pharmaceuticl yet.

Aeolus Pharmaceuticl stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Aeolus Pharmaceuticl

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound inc…

Full company profile